In CML, the constitutively active BCR::ABL1 kinase drives leukaemic proliferation through stimulation of several key cell survival pathways frequently activated in cancer. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.